Roberta Murru

853 total citations
12 papers, 133 citations indexed

About

Roberta Murru is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Roberta Murru has authored 12 papers receiving a total of 133 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 4 papers in Pathology and Forensic Medicine and 4 papers in Hematology. Recurrent topics in Roberta Murru's work include Chronic Lymphocytic Leukemia Research (7 papers), Lymphoma Diagnosis and Treatment (4 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). Roberta Murru is often cited by papers focused on Chronic Lymphocytic Leukemia Research (7 papers), Lymphoma Diagnosis and Treatment (4 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). Roberta Murru collaborates with scholars based in Italy, United States and Switzerland. Roberta Murru's co-authors include Emanuele Angelucci, Simona Deplano, Daniele Alberti, B. Rabault, G. B. Melis, Carlo Carcassi, Marco Angiolucci, Valerio Mais, Claudio Romani and Silvana Anna Maria Urru and has published in prestigious journals such as Blood, Cancers and Ultrasound in Obstetrics and Gynecology.

In The Last Decade

Roberta Murru

12 papers receiving 133 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberta Murru Italy 6 73 50 32 23 21 12 133
Candice Del Rio United States 6 36 0.5× 43 0.9× 59 1.8× 33 1.4× 5 0.2× 8 128
Andrei Coliţă Romania 7 54 0.7× 90 1.8× 30 0.9× 24 1.0× 7 0.3× 38 153
Kyung Taek Hong South Korea 8 37 0.5× 54 1.1× 13 0.4× 30 1.3× 27 1.3× 54 165
Pierre Cougoul France 7 60 0.8× 43 0.9× 7 0.2× 10 0.4× 18 0.9× 32 125
Alessandra Stasia Italy 4 37 0.5× 116 2.3× 21 0.7× 43 1.9× 5 0.2× 6 144
Concepción Nicolás Spain 6 93 1.3× 22 0.4× 102 3.2× 42 1.8× 16 0.8× 10 191
Jesús Arias Spain 4 112 1.5× 38 0.8× 105 3.3× 45 2.0× 14 0.7× 13 225
Ghada Abusin United States 7 30 0.4× 56 1.1× 13 0.4× 14 0.6× 13 0.6× 15 119
N. Peter Germany 7 28 0.4× 80 1.6× 40 1.3× 60 2.6× 19 0.9× 8 167
George Chan New Zealand 7 30 0.4× 79 1.6× 57 1.8× 47 2.0× 5 0.2× 18 172

Countries citing papers authored by Roberta Murru

Since Specialization
Citations

This map shows the geographic impact of Roberta Murru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Murru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Murru more than expected).

Fields of papers citing papers by Roberta Murru

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Murru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Murru. The network helps show where Roberta Murru may publish in the future.

Co-authorship network of co-authors of Roberta Murru

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta Murru. A scholar is included among the top collaborators of Roberta Murru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta Murru. Roberta Murru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Murru, Roberta, et al.. (2024). Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis. Annals of Hematology. 103(5). 1655–1664. 4 indexed citations
2.
Maccaferri, Monica, et al.. (2024). Chronic Lymphocytic Leukemia: Management of Adverse Events in the Era of Targeted Agents. Cancers. 16(11). 1996–1996. 5 indexed citations
3.
Murru, Roberta, Giovanni Caocci, Marianna Greco, et al.. (2022). Patients with Chronic Lymphocytic Leukemia Have a Very High Risk of Ineffective Response to the BNT162b2 Vaccine. Vaccines. 10(7). 1162–1162. 2 indexed citations
5.
Molica, Stefano, Potito Rosario Scalzulli, Lydia Scarfò, et al.. (2021). The Use of Ibrutinib in Italian CLL Patients Treated in a Real-World Setting (EVIDENCE): A Preliminary Report. Blood. 138(Supplement 1). 4684–4684. 2 indexed citations
6.
Caocci, Giovanni, Olga Mulas, Alessandro Nanni Costa, et al.. (2021). Should be a Third Dose of BNT162b2 mRNA COVID-19-Vaccine Administered in Patients with Myelofibrosis Under Ruxolitinib?. Blood. 138(Supplement 1). 2573–2573. 1 indexed citations
7.
Mauro, Francesca Romana, Piero Galieni, Alessandra Tedeschi, et al.. (2017). Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma. American Journal of Hematology. 92(6). 529–535. 14 indexed citations
8.
Autore, Francesco, Paolo Strati, Idanna Innocenti, et al.. (2016). LDH Levels Predict Progression-Free Survival in Treatment-NaÏVe Patients with Trisomy 12 Chronic Lymphocytic Leukemia. Blood. 128(22). 3211–3211. 2 indexed citations
9.
Urru, Silvana Anna Maria, et al.. (2014). Acute Pancreatitis Following Brentuximab Vedotin Therapy for Refractory Hodgkin Lymphoma: A Case Report. Drugs in R&D. 14(1). 9–11. 18 indexed citations
10.
Angiolucci, Marco, Roberta Murru, G. B. Melis, Carlo Carcassi, & Valerio Mais. (2010). Association between different morphological types and abnormal karyotypes in early pregnancy loss. Ultrasound in Obstetrics and Gynecology. 37(2). 219–225. 24 indexed citations
11.
Romani, Claudio, et al.. (2009). Sinusal bradycardia after receiving intermediate or high dose cytarabine: four cases from a single institution. European Journal of Cancer Care. 18(3). 320–321. 8 indexed citations
12.
Murru, Roberta, et al.. (2007). Correction of anemia in a transfusion‐dependent patient with primary myelofibrosis receiving iron chelation therapy with deferasirox (Exjade®, ICL670). European Journal Of Haematology. 78(6). 540–542. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026